INVO Fertility Sets 1:4 Reverse Split Effective Oct. 30
IVF sits 18% above its 52-week low of $0.51.
Summary
INVO Fertility will execute a 1:4 reverse stock split effective before the market opens on Oct. 30. The move consolidates every four pre-split shares into one, lifting the quoted price from around $0.60 to roughly $2.40 while leaving the company's value unchanged. This is the second reverse split this year, following the 1:5 split that took effect March 27, and it comes as the company remains a going concern with highly dilutive financing, including a $50M equity line and debt carrying a death-spiral clause. The split is likely aimed at restoring compliance with Nasdaq's minimum bid price requirement, though the company has not stated that in the headline. Watch whether the post-split price holds above $1 and whether another equity draw follows.
At the time of this announcement, IVF was trading at $0.60 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.9M. The 52-week trading range was $0.51 to $26.58. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.